Unfortunately, if any of the following apply to you, this study is not the right fit for you:

• Under the age of 18
• Not currently caring for someone diagnosed with mild Alzheimer's
• Have not been diagnosed with mild Alzheimer's Disease

Eligible participants can complete the 25 minute online survey using their computer or tablet device (at least 10 inch screen size).

Community and Patient Preference Research (CaPPRe), an independent research organisation, is conducting research with people who are for someone living with mild Alzheimer's Disease and with people who have been diagnosed with mild Alzheimer's Disease.

Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It is the most common cause of dementia, characterized by a decline in cognitive abilities, making it difficult for individuals to carry out daily activities. The disease involves the buildup of abnormal proteins in the brain, leading to the death of brain cells. Early symptoms typically include memory loss and confusion, which worsen over time, affecting a person’s ability to communicate and perform tasks. Although there is no cure, treatments aim to manage symptoms and improve quality of life.

This study is important as it aims to better understand the treatment preferences of both individuals living with mild Alzheimer’s Disease and their caregivers. By exploring what matters most to them, the research will help improve treatment options and care strategies, ensuring they are more personalised and patient-centred. The findings could lead to better outcomes and quality of life for those affected by Alzheimer’s, while also guiding future healthcare policies.

This study is being sponsored by Community and Patient Preference Research (CaPPRe), an independent research organisation.

We are here for you! Head to our Evrima Help Centre and search for answers relating to clinical trials, study information and managing your Evrilink account